Cargando…
MET 14外显子跳跃突变在非小细胞肺癌中的研究进展
Recently, targeted therapy has achieved great success in the treatment of non-small cell lung cancer (NSCLC) patients. Mesenchymal to epithelial transition factor (MET) is considered to be another important molecular target for NSCLC since epidermal growth factor receptor (EGFR) and anaplastic lymph...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058657/ https://www.ncbi.nlm.nih.gov/pubmed/30037377 http://dx.doi.org/10.3779/j.issn.1009-3419.2018.07.09 |